Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:34 pm Purchase |
2024-09-30 | 13G | Ondas Holdings Inc. ONDS |
ARMISTICE CAPITAL LLC | 4,750,000 6.310% |
4,750,000 (New Position) |
Filing History |
| 2024-11-14 3:34 pm Purchase |
2024-09-30 | 13G | MetaVia Inc. MTVA |
ARMISTICE CAPITAL LLC | 848,000 9.990% |
848,000 (New Position) |
Filing History |
| 2024-11-14 3:33 pm Purchase |
2024-09-30 | 13G | NLS Pharmaceutics AG NLSP |
ARMISTICE CAPITAL LLC | 129,475 9.990% |
129,475 (New Position) |
Filing History |
| 2024-11-14 3:33 pm Purchase |
2024-09-30 | 13G | Mobix Labs, Inc. MOBX |
ARMISTICE CAPITAL LLC | 2,336,000 7.480% |
2,336,000 (New Position) |
Filing History |
| 2024-11-14 3:32 pm Purchase |
2024-09-30 | 13G | LM Funding America, Inc. LMFA |
ARMISTICE CAPITAL LLC | 297,340 9.990% |
297,340 (New Position) |
Filing History |
| 2024-11-14 3:32 pm Purchase |
2024-09-30 | 13G | Pasithea Therapeutics Corp. KTTA |
ARMISTICE CAPITAL LLC | 115,880 9.990% |
115,880 (New Position) |
Filing History |
| 2024-11-14 3:32 pm Purchase |
2024-09-30 | 13G | Iveda Solutions, Inc. IVDA |
ARMISTICE CAPITAL LLC | 236,263 9.990% |
236,263 (New Position) |
Filing History |
| 2024-11-14 3:31 pm Purchase |
2024-09-30 | 13G | Iterum Therapeutics plc ITRM |
ARMISTICE CAPITAL LLC | 1,340,000 6.030% |
1,340,000 (New Position) |
Filing History |
| 2024-11-14 3:31 pm Purchase |
2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
ARMISTICE CAPITAL LLC | 8,200,000 5.130% |
8,200,000 (New Position) |
Filing History |
| 2024-11-14 3:31 pm Purchase |
2024-09-30 | 13G | Inhibikase Therapeutics, Inc. IKT |
ARMISTICE CAPITAL LLC | 758,885 9.990% |
758,885 (New Position) |
Filing History |
| 2024-11-14 3:30 pm Purchase |
2024-09-30 | 13G | Gaxos.ai Inc. GXAI |
ARMISTICE CAPITAL LLC | 207,632 9.990% |
207,632 (New Position) |
Filing History |
| 2024-11-14 3:30 pm Purchase |
2024-09-30 | 13G | 5E Advanced Materials Inc. FEAM |
ARMISTICE CAPITAL LLC | 216,522 7.230% |
216,522 (New Position) |
Filing History |
| 2024-11-14 3:29 pm Purchase |
2024-09-30 | 13G | Evaxion Biotech A/S EVAX |
ARMISTICE CAPITAL LLC | 111,055 9.990% |
111,055 (New Position) |
Filing History |
| 2024-11-14 3:29 pm Purchase |
2024-09-30 | 13G | Enlivex Therapeutics Ltd. ENLV |
ARMISTICE CAPITAL LLC | 2,175,884 9.990% |
2,175,884 (New Position) |
Filing History |
| 2024-11-14 3:29 pm Purchase |
2024-09-30 | 13G | Ekso Bionics Holdings, Inc. EKSO |
ARMISTICE CAPITAL LLC | 9,745 9.990% |
7,973 (+449.98%) |
Filing History |
| 2024-11-14 3:28 pm Purchase |
2024-09-30 | 13G | Edible Garden AG Incorporated EDBL |
ARMISTICE CAPITAL LLC | 82,091 9.990% |
82,091 (New Position) |
Filing History |
| 2024-11-14 3:28 pm Purchase |
2024-09-30 | 13G | Danimer Scientific, Inc. DNMR |
ARMISTICE CAPITAL LLC | 12,018,677 9.900% |
12,018,677 (New Position) |
Filing History |
| 2024-11-14 3:27 pm Purchase |
2024-09-30 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF |
ARMISTICE CAPITAL LLC | 408,110 9.990% |
408,110 (New Position) |
Filing History |
| 2024-11-14 3:27 pm Purchase |
2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
ARMISTICE CAPITAL LLC | 13,916 9.990% |
13,916 (New Position) |
Filing History |
| 2024-11-14 3:26 pm Purchase |
2024-09-30 | 13G | Clene Inc. CLNN |
ARMISTICE CAPITAL LLC | 700,000 8.770% |
700,000 (New Position) |
Filing History |